Back to search
FDAFDA · Food and drugs·Recall number Z-0972-2014

TSX-301C Aquilion One (Vision Edition) Computed Tomography X-Ray System.

Published March 12, 2014 · Recall initiated: December 11, 2013

Summary

FDA records medical device Class II recall Z-0972-2014, published March 12, 2014 and initiated December 11, 2013. Recalling firm: Toshiba American Medical Systems Inc; Status: Terminated; Reported quantity: 8 units; Lot: SERIAL NO.: 1CB1262006, 1DB1312033, 1DC1352070, 1DB1342060, 1DB1332049, 1DC1382081, 1DB1312027, 1DB1332045, 1DC1362073, 1CB12X2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Toshiba America Medical Systems, Inc. initiated this recall due to the failure of the parts used in the X-ray high-voltage generator. In some cases, X-ray exposure cannot be performed.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Toshiba American Medical Systems Inc
Distributor
US Distribution including the states of: MD, WV, OH, CA, MN, IN, NY and WI.
Lot
SERIAL NO.: 1CB1262006, 1DB1312033, 1DC1352070, 1DB1342060, 1DB1332049, 1DC1382081, 1DB1312027, 1DB1332045, 1DC1362073, 1CB12X2018.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was TSX-301C Aquilion One (Vision Edition) Computed Tomography X-Ray System. recalled?

Yes. FDA published recall Z-0972-2014 on March 12, 2014. Reported hazard: Toshiba America Medical Systems, Inc. initiated this recall due to the failure of the parts used in the X-ray high-voltage generator. In some cases, X-ray exposure cannot be performed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter